Complications

Complication
Timeframe
Likelihood
long term
high

Both oestrogens and androgens increase appetite, so unless actual consumption is kept constant, weight gain will result.

Obesity in adults

long term
low

Oestrogen treatment raises the risk of thromboembolic disease, particularly in smokers.[31]​ Non-smoking status should be strongly recommended prior to treatment. For those with non-modifiable risk factors which may increase the risk of thromboembolic disease, e.g. a known history of thrombophilia, a past history of thrombosis, or a strong family history of thromboembolism, offering an anticoagulant in addition to treatment with transdermal oestrogen may decrease the risk of thromboembolism, although data to guide treatment decisions are extremely limited.[4]

Deep vein thrombosis

long term
low

Particularly before hysterectomy and oophorectomy, when higher doses of androgens may sometimes be employed to achieve menopause.

The American College of Obstetricians and Gynaecologists list polycythaemia (haematocrit greater than 55%) as an absolute contraindication to testosterone treatment.[44]

Androgen treatment raises haematocrit, particularly in smokers. Hysterectomy and oophorectomy may allow dose reduction, or phlebotomy may be needed.[57]

long term
low

Particularly at outset of treatment.

Oestrogens and androgens can cause prolactin to rise. Only levels of over 1000 IU require endocrine advice.[57]

Assessment of hyperprolactinaemia

long term
low

Dyslipidaemia is not common, but is worthwhile monitoring. If apparent it is treated in the usual manner with diet and statins.

long term
low

Bone mass is generally preserved with use of either sex steroid. The risk of osteoporosis is increased for patients who stop sex hormone treatment following gonadectomy.[31]​ Screening for osteoporosis is recommended for patients with risk factors, and in particular for those who stop hormone treatment following gonadectomy.[31]

Osteoporosis

variable
medium

Trangender people are at increased risk for mental health problems, including suicidal ideation, prior to gender-affirming treatment and legal gender change. This risk may persist after gender reassignment if the individual struggles to adjust.[2]​ Furthermore, a number of external social factors including stigma, discrimination, and minority stress have been suggested as contributing factors.[15]​ Primary care screening and assessment for mental health conditions is likely to be valuable on an ongoing basis.

Use of this content is subject to our disclaimer